ARIAD PHARMACEUTICALS INC 4

4 · ARIAD PHARMACEUTICALS INC · Filed Mar 3, 2016

Form 4

Period: 2016-03-01

SVP, Corporate Affairs

Transactions

Exercise/Conversion
Common Stock
2016-03-01+19,250→ 142,367 total
Sale
Common Stock
2016-03-03$6.12/sh−9,625$58,869→ 132,742 total
Exercise/Conversion
Performance stock unit
2016-03-01−19,250→ 19,250 total
→ Common Stock (19,250 underlying)
Award
Performance stock unit
2016-03-01+38,500→ 38,500 total
→ Common Stock (38,500 underlying)

Footnotes (5)

[F1]Shares were acquired upon vesting of performance stock units awarded on January, 31, 2014.
[F2]Represents shares sold to satisfy withholding tax requirements, pursuant to a Rule 10b5-1 trading plan.
[F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.04 to $6.20, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Security and Exchange Commission, upon request, full information regarding the shares sold at each separate price within the range set forth in this footnote.
[F4]Each performance stock unit represents a right to receive one share of ARIAD common stock.
[F5]The performance stock units vest as to 50% of the award on 3/1/2016 and 50% of the award on 3/1/2017.

Documents

1 file